Biotech Antengene to Present Results from Three Programs at the 2024 SITC Annual Meeting October 5, 2024
Biotech Biopharmaceutical Research Company Announces First Dose of BRC-002, a First-in-Class Cannabinoid Therapeutic for Complex Regional Pain Syndrome (CRPS), in Investigator-Initiated Study October 4, 2024
Biotech Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment October 3, 2024
Biotech AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team October 2, 2024
Biotech Resolution Therapeutics Announces Upcoming Presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2024 October 1, 2024
Biotech New Beginnings, New Journey | Sanyou Opening of New 10,000-sqm Facility, Ushering in a New Era of Innovation for Bio Drugs September 29, 2024
Biotech AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer September 28, 2024
Biotech FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia September 27, 2024
Biotech CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight September 26, 2024
Search
Biotech
October 5, 2024
October 4, 2024
October 3, 2024
October 2, 2024
October 1, 2024
September 30, 2024
September 29, 2024
September 28, 2024
September 27, 2024
September 26, 2024
